Cutting Edge: Acute Lung Allograft Rejection Is Independent of Secondary Lymphoid Organs

It is the prevailing view that adaptive immune responses are initiated in secondary lymphoid organs. Studies using alymphoplastic mice have shown that secondary lymphoid organs are essential to initiate allograft rejection of skin, heart, and small bowel. The high immunogenicity of lungs is well rec...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of immunology (1950) 2009-04, Vol.182 (7), p.3969-3973
Hauptverfasser: Gelman, Andrew E, Li, Wenjun, Richardson, Steven B, Zinselmeyer, Bernd H, Lai, Jiaming, Okazaki, Mikio, Kornfeld, Christopher G, Kreisel, Friederike H, Sugimoto, Seiichiro, Tietjens, Jeremy R, Dempster, John, Patterson, G. Alexander, Krupnick, Alexander S, Miller, Mark J, Kreisel, Daniel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:It is the prevailing view that adaptive immune responses are initiated in secondary lymphoid organs. Studies using alymphoplastic mice have shown that secondary lymphoid organs are essential to initiate allograft rejection of skin, heart, and small bowel. The high immunogenicity of lungs is well recognized and allograft rejection remains a major contributing factor to poor outcomes after lung transplantation. We show in this study that alloreactive T cells are initially primed within lung allografts and not in secondary lymphoid organs following transplantation. In contrast to other organs, lungs are acutely rejected in the absence of secondary lymphoid organs. Two-photon microscopy revealed that recipient T cells cluster predominantly around lung-resident, donor-derived CD11c(+) cells early after engraftment. These findings demonstrate for the first time that alloimmune responses following lung transplantation are initiated in the graft itself and therefore identify a novel, potentially clinically relevant mechanism of lung allograft rejection.
ISSN:0022-1767
1550-6606
DOI:10.4049/jimmunol.0803514